Sector: MedicalNeurocrine Biosciences, Inc. (NASDAQ: NBIX)
Ranking History
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 224 |
Technical : | 291 |
Performance : | 284 |
Overall: | 300 |
Number of Stocks: | 306 |
Scan Date: | 10/20/2009 |
Sector: | Medical |
Funamental : | 227 |
Technical : | 236 |
Performance : | 274 |
Overall: | 297 |
Number of Stocks: | 305 |
Scan Date: | 10/15/2009 |
Sector: | Medical |
Funamental : | 229 |
Technical : | 299 |
Performance : | 266 |
Overall: | 302 |
Number of Stocks: | 305 |
Headlines
- Neurocrine Biosciences Reports Third Quarter 2009 Results
Oct 28, 2009 04:05 PM | NBIX
- Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2009 Financial Results
Oct 23, 2009 02:05 PM | NBIX
- Neurocrine Biosciences Amends Corporate Headquarters Lease
Oct 01, 2009 04:15 PM | NBIX
- Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
Sep 16, 2009 12:00 PM | NBIX, UBS
- Neurocrine Biosciences Secures Committed Equity Financing Facility
Sep 15, 2009 04:38 PM | NBIX
- Neurocrine Biosciences to Present at the Thomas Weisel Partners Healthcare Conference
Sep 02, 2009 12:00 PM | NBIX
- Market Commentary (02-02-09)
Feb 03, 2009 09:33 AM | ACTL, ADM, ADP, ADVS, AMSC, ASYS
- Analyst Comments: NetEase.com, Neurocrine Bio, L-3 Communications, Brasil Telecom, Quality Systems, H&R Block
Sep 05, 2008 02:36 PM | BRP, HRB, LLL, NBIX, NTES, NZT
- Few Thoughts and a Look at the Earnings in the Coming Week
Jul 28, 2008 01:20 AM | ABCO, ACAP, ACLI, ACLS, ACXM, ADPT
- Analyst Comments: Neurocrine Biosciences, Humana, OPNET, Sallie Mae, News Corporation, Telesp, Marathon, Telemig
Feb 07, 2008 08:06 PM | BRP, HUM, MRO, NBIX, NWS, OPNT
- Webcast Alert: Neurocrine Biosciences Announces 2nd Quarter 2009 Earnings Results
Jul 30, 2009 07:46 AM | NBIX
- Neurocrine Biosciences Reports Second Quarter 2009 Results
Jul 29, 2009 04:06 PM | NBIX
- Elagolix Successful in Six Month Lilac Petal Study; Safety and Efficacy Confirmed in Patients With Endometriosis
Jul 29, 2009 09:02 AM | NBIX
- Webcast Alert: Neurocrine Biosciences Announces 2nd Quarter 2009 Earnings Results
Jul 27, 2009 02:11 PM | NBIX
- Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2009 Financial Results
Jul 23, 2009 04:21 PM | NBIX
- Neurocrine Biosciences Presents Elagolix Data
Jun 16, 2009 04:10 PM | NBIX
- Neurocrine Biosciences to Present at the 8th Annual Needham Life Sciences Conference
Jun 04, 2009 12:00 PM | NBIX
- Neurocrine Announces Full Year Results from 603 Study (Petal Study) of Elagolix for Treatment of Endometriosis Pain
May 18, 2009 02:16 PM | NBIX
- Neurocrine Biosciences to Present at the Deutsche Bank 34th Annual Health Care Conference
May 11, 2009 12:00 PM | NBIX
- Neurocrine Biosciences Reports First Quarter 2009 Results
May 05, 2009 04:06 PM | NBIX
- Form 4 NEUROCRINE BIOSCIENCES For: Nov 05 Filed by: MITCHELL W THOMAS (10K)
Nov 06, 2009 05:00 PM
- Form 4 OBrien Christopher Flint For: Sep 28 (10K)
Sep 30, 2009 06:42 PM
- Form 4 Grigoriadis Dimitri E. For: Sep 28 (10K)
Sep 30, 2009 06:41 PM
- Form 4 Bozigian Haig P. For: Sep 28 (10K)
Sep 30, 2009 06:37 PM
- Form 4 NEUROCRINE BIOSCIENCES For: Aug 28 Filed by: GORMAN KEVIN CHARLES (10K)
Sep 01, 2009 06:49 PM
- Form 4 Coughlin Timothy P For: Aug 28 (10K)
Sep 01, 2009 06:47 PM
- Form 4 NEUROCRINE BIOSCIENCES For: Aug 28 Filed by: MOLLICA JOSEPH A (10K)
Sep 01, 2009 06:39 PM
- Form 4 SHERWIN STEPHEN A For: Aug 28 (10K)
Sep 01, 2009 06:37 PM
- Form 4 LYLE CORINNE H For: Aug 28 (10K)
Sep 01, 2009 06:35 PM
- Form 4 VALE WYLIE W For: Aug 28 (10K)
Sep 01, 2009 06:34 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
NBIX
|
Compare to S&P
|
| YTD |
-30.63 %
|
-39.53 %
|
| 4 Weeks |
-21.28 %
|
-22.11 %
|
| 12 Weeks |
-27.69 %
|
-29.48 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 43.24 %
|
|
EPS Growth in Last Year: 54.35 %
|
|
Sales Growth in Last Quarter: 0.00 %
|
|
Sales Growth in Last Quarter: -3.68 %
|
|
